News related to Nexavar (Sorafenib) and/or conditions it is approved for
Nivolumab Approved for Liver Cancer Source: Medscape Gastroenterology Headlines [2017.09.25] The FDA has approved the immunotherapy for use in patients with hepatocellular carcinoma who have previously been treated with sorafenib. FDA Approvals